Results 141 to 150 of about 55,779 (204)

Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial. [PDF]

Hum Vaccin Immunother
Perroud A, Madruga JVR, Fernandes L, Luz K, Lukic N, Bourée S, Sanchez-Ruiz M, Pegoraro F, Petit C, Zambrano B, Dayan G.   +10 more
europepmc   +1 more source

Immunogenicity, Safety, and Efficacy of a Tetravalent Dengue Vaccine in Children and Adolescents: An Analysis by Age Group. [PDF]

Clin Infect Dis
Borja-Tabora C, Fernando L, Lopez Medina E, Reynales H, Rivera L, Saez-Llorens X, Sirivichayakul C, Yu D, Folschweiller N, Moss KJ, Rauscher M, Tricou V, Zhao Y, Biswal S.   +13 more
europepmc   +1 more source

Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains. [PDF]

PLoS Negl Trop Dis
Velasco JM, Klungthong C, Chinnawirotpisan P, Diones PC, Valderama MT, Leonardia S, Manasatienkij W, Joonlasak K, Rodpradit P, Mateo J, Vila V, Navarro FC, Jones A, Farmer A, Fernandez S.   +14 more
europepmc   +1 more source

Defeating dengue: a challenge for a vaccine [PDF]

Nature Medicine, 2012
openaire   +2 more sources

Localized Inflammation in Dengue Vaccine-Induced Skin Rash Is Not Associated with Continuous Presence of Dengue Virus Genome. [PDF]

J Invest Dermatol
Strother C, Bouffard N, Smolynets O, Graham NR, Elko EA, Sabundayo B, Durbin AP, Whitehead SS, Taatjes DJ, Kirkpatrick BD, Greene L, Pierce KK, Diehl SA.   +12 more
europepmc   +1 more source

Travel medicine providers' opinions on the dengue vaccine TAK-003 as a travel vaccine and the need for decision-support information and materials before its launch in Japan. [PDF]

Hum Vaccin Immunother
Fukunishi A, Machida M, Fukushima S, Inoue S.   +3 more
europepmc   +1 more source

Long term T cell response and safety of a tetravalent dengue vaccine in healthy children. [PDF]

NPJ Vaccines
Mandaric S, Friberg H, Saez-Llorens X, Borja-Tabora C, Biswal S, Escudero I, Faccin A, Gottardo R, Brose M, Roubinis N, Fladager D, DeAntonio R, Dimero JAL, Montenegro N, Folschweiller N, Currier JR, Sharma M, Tricou V.   +17 more
europepmc   +1 more source

Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis. [PDF]

Vaccines (Basel)
Flacco ME, Bianconi A, Cioni G, Fiore M, Calò GL, Imperiali G, Orazi V, Tiseo M, Troia A, Rosso A, Manzoli L.   +10 more
europepmc   +1 more source

Knowledge, attitude, and practice regarding dengue vaccine: a baseline study of community members and health providers in Indonesia. [PDF]

Clin Exp Pediatr
Wahab A, Laksanawati IS, Padmawati RS, Mulyadi AWE, Triadmajani W, Thobari JA.   +5 more
europepmc   +1 more source

Role of the dengue vaccine TAK-003 in an outbreak response: Modeling the Sri Lanka experience. [PDF]

PLoS Negl Trop Dis
Fernando L, Kastner R, Wickramasinghe P, Fernando AD, Gunasekera D, Nguyen VH, Liu M, LeFevre I, Wallace D, Folschweiller N, Biswal S.   +10 more
europepmc   +1 more source